Resultados de la búsqueda 341-350 of 15787 for Digoxin toxicity

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared ...